You need to be logged in to continue.
Please Login or Register
You can no longer receive credit for taking this course
Release Date: May 27, 2011
Expiration Date: May 27, 2012
Expected time to complete this activity as designed: 60 minutes
Opioid analgesics are frequently used for the management of both acute and chronic pain. However, a number of significant clinical issues continue to hamper the effective use of opioid analgesics: clinician barriers including having gaps in knowledge, competence and skills, attitudes toward prescribing opioids, and inadequate assessment skills; patient-related barriers including communication, education, psychological, and attitudinal issues; and health care system barriers including lack of access to multidisciplinary team members and insurance reimbursement issues.
Dr. Sitzman provides a global and informative overview of the “ten commandments” to addressing these potential barriers to maximize treatment outcomes in chronic pain management.
This activity is designed for physicians and pharmacists who have an interest in enhancing their clinical skills in pain management.
Upon completion of this educational activity, participants should be able to:
- Summarize clinical issues surrounding opioid prescribing and identify practical methods clinicians may use to contain risk
- Identify advances in understanding and managing chronic pain as it relates to opioid therapy
This activity is eligible for credit through May 27, 2012. After this date, the activity will expire and no further credit will be awarded. There are no fees for participating in or receiving credit for this online educational activity.
Follow these steps to earn CME/CE credit:
- Read the target audience, learning objectives, and author disclosures.
- You may be asked to complete a short pre-test before accessing the educational content.
- Complete the educational content online as designed or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score of 70% on the test and complete the Activity Evaluation to provide feedback for future programming.
Certificates may be printed immediately after successfully completing the online self-assessment post-activity and evaluation.
Scott M. Fishman, MD – Moderator
Chief, Division of Pain Medicine
Vice Chair for Pain Medicine and Faculty Development
Professor of Anesthesiology and Pain Medicine
University of California, Davis
Dr. Scott Fishman is chief of the Division of Pain Medicine, vice chair for pain medicine and faculty development, and professor of anesthesiology and pain medicine at the University of California, Davis. He received his medical degree from the University of Massachusetts Medical School, his formal clinical training in internal medicine and psychiatry, and completed pain medicine fellowship training through the Department of Anesthesia and Critical Care at Massachusetts General Hospital. Dr. Fishman has received board certification in internal medicine, psychiatry, pain medicine, and palliative medicine.
Dr. Fishman is president and chairman of the board for the American Pain Foundation. He advocates for the field of pain medicine with consumers and lawmakers, and serves as a consultant to numerous government agencies. He has authored The War on Pain; Listening to Pain; Responsible Opioid Prescribing; and has co-authored The Massachusetts General Hospital Handbook of Pain Management; Essentials of Pain Medicine and Regional Anesthesia; Spinal Cord Stimulation: Implantation Techniques; and Bonica’s Management of Pain, 4th edition. He has also authored many peer-reviewed articles, book chapters, and other scholarly reviews. Dr. Fishman is senior editor of Pain Medicine and serves on the editorial boards of numerous medical journals. He lectures throughout the US on all aspects of pain and its treatment. In addition, Dr. Fishman has spoken about pain on the Today Show, Good Morning America, and the ABC Nightly News, and has been quoted in The New York Times, The Wall Street Journal, Time Magazine and Newsweek, and has served as the pain expert for Discoveryhealth.com.
B. Todd Sitzman, MD, MPH
Advanced Pain Therapy
Dr. Todd Sitzman received his medical and master of public health degrees from Tulane University in New Orleans. Following an internship in internal medicine at the Hospital of the University of Pennsylvania in Philadelphia, he received anesthesiology and pain management training at the University of Virginia Health Sciences Center in Charlottesville. Dr. Sitzman is the medical director of Advanced Pain Therapy, a comprehensive pain clinic located in Hattiesburg, Mississippi. He also serves as the medical consultant for the pain management program at Forrest General Hospital and Forrest General Cancer Center.
Dr. Sitzman is board certified in anesthesiology and pain medicine. He has served on the board of directors of the American Academy of Pain Medicine, North American Neuromodulation Society, Southern Pain Society, and Mississippi Pain Society. In addition, Dr. Sitzman is an active member of numerous national and international pain societies, and is past president of the Southern Pain Society and the American Academy of Pain Medicine. He has authored more than 70 scientific publications including abstracts, manuscripts, and book chapters, and serves on the editorial boards of the journals Pain Medicine and Pain Practice. He is actively involved in patient advocacy and postgraduate medical education, and lectures nationally and internationally on topics related to pain pharmacology and interventional pain therapies. Dr. Sitzman has been interviewed and quoted in Parade Magazine, ABC News, The New York Times, USA Today, WebMD, Pain Medicine News, and American Medical News.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.0 contact hour of Continuing Education Credit. Universal Activity Number: 827-0000-11-279-H01-P. Knowledge-based CPE activity.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly the following disclosures were made.
Dr. Scott Fishman has disclosed no relevant financial relationships with the grantor or any other commercial company whose products and services may be related to his presentation.
Dr. Todd Sitzman has received consultant fees from URL Pharma, Inc. and Johnson & Johnson Development Corporation.
Planning Committee Disclosures
The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, Bronwyn Boyes, PharmD, director, and Alan Vogenberg, RPh, FASCP, clinical advisor, have no relevant financial relationships.
Adam J. Carinci, MD, was the clinical reviewer for this activity and has no relevant financial relationships.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees / participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Dr. Fishman and Dr. Sitzman have indicated that their presentations would not include the discussion of unlabeled uses of commercial products or investigational products not yet approved by the FDA for any use in the United States.
MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at firstname.lastname@example.org.
Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Purdue Pharma.
©2011 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.
You need to be logged in to continue.
Please Login or Register
In the News
- Motives for Medical Misuse of Prescription Opioids Among Adolescents - 2013-12-06
- Lack of association between DRD2 and OPRM1 genotypes and adiposity - 2013-12-06
- A Preliminary Study to Determine if a Muscle Pain Protocol Can Produce Long-Term Relief in Chronic Back Pain Patients - 2013-12-05
- Risk of QTc Prolongation in a Cohort of Opioid-Dependent HIV-Infected Patients on Methadone Maintenance Therapy - 2013-12-05
- A Phase 3, Randomized, Double-Blind Comparison of Analgesic Efficacy and Tolerability of Q8003 vs Oxycodone or Morphine for Moderate-to-Severe Postoperative Pain Following Bunionectomy Surgery - 2013-12-04